Enrolling by invitationPhase 1NCT06429007

A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Boston Children's Hospital
Principal Investigator
Brian Kalish, MD
Boston Children's Hospital
Intervention
Metformin(drug)
Enrollment
30 target
Eligibility
All sexes
Timeline
20252029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06429007 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials